AI Image
Preclinical research at BYU may lead to development of low-cost immunotherapy
KSL News • • health
Key Points:
- Researchers at Brigham Young University are developing MOTO-CAR, a technology that genetically engineers immune cells to identify and attack cancer cells.
- In pre-clinical lab tests, MOTO-CAR achieved a 90% reduction in aggressive lung cancer cells within 24 hours.
- The technology aims to treat hard-to-cure cancers by harnessing the patient’s immune system, potentially reducing reliance on surgery, chemotherapy, or radiation.
- BYU professor Kim O'Neill emphasized efforts to make the treatment affordable and accessible worldwide.
- Further research is required before MOTO-CAR can proceed to human clinical trials.
